Learn more about tirzepatide
Polyethylene Glycol Loxenatide injection (GLP-1) protects vascular endothelial cell function in middle-aged and elderly patients with type 2 diabetes by regulating gut microbiota
Keep different peptide injection sites separated by at least 2 inches
Wegovy is now the first weight-loss medication to also be approved to help prevent life-threatening cardiovascular events in adults with cardiovascular disease and either obesity or overweight, says John Sharretts, MD, director of the division of diabetes, lipid disorders, and obesity in the FDAs Center for Drug Evaluation and Research, in a release
Rotate through the injection sites each week to prevent discomfort, irritation, and scar tissue formation
Personalized Doctor Evaluation Connect with an Arizona-based physician via video call